Peter Wick is the current head of Nanomaterials in Health at Empa, where they hold personnel and budget responsibilities while actively working in committee roles, including the Swiss National COVID-19 Science Task Force. With a strong background in basic and applied research, they successfully transitioned nanosafety activities into nanomedicine and have acquired funding from various sources, including SNSF and the EU. Peter teaches at ETH Zürich, focusing on Nanostructured Materials Safety and Nanomaterials for Health, and is recognized internationally as an expert in nanosafety and nanomedicine. They hold a Ph.D. in Cell and Molecular Biology from the Université de Fribourg/Universität Freiburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices